Fact Sheet: Kellogg Facts, Figures and Firsts

Profile

• Chair: Paul P. Lee, M.D., J.D.
• Clinical faculty: 64
• Research faculty: 21
• History: The Department of Ophthalmology was established in 1872
• Endowed professorships: 9
• Institutional organization: The W.K. Kellogg Eye Center is home to the University of Michigan Department of Ophthalmology and Visual Sciences, which is part of the University of Michigan Medical School and the University of Michigan Health System

Education and Training

• Residency Program Director: Shahzad I. Mian, M.D.
• Residents: 21
• Clinical fellows: 11
• Research fellows: 17
• Alumni: 500 active alumni across the country and around the world

Medical facilities

• In March 2010, the new 8-story Brehm Tower, a 230,000 sq. ft. addition to the Kellogg Eye Center, opened with 9 eye clinics, 6 operating rooms, and new suites for refractive surgery and cosmetic surgery.
• Supporting services include genetic counseling, ophthalmic photography, diagnostic electrophysiological testing, and ocular prosthetics. A library, optical shop, and café are also on site. Our 20 research laboratories are located in the new building and in the adjoining research tower.
• The Kellogg Eye Center has community clinics in: Ann Arbor, Brighton, Canton, Livonia, Milford, West Bloomfield, and Ypsilanti.
• The Veterans Affairs Hospital is a 100-bed acute care facility. The VA Ophthalmology Clinic has 12 exam lanes, plus an ophthalmic photography/ultrasound room and resident office space. Residents who staff this clinic see 16,500 patients and perform 2,080 surgical procedures each year.

Patient visits

• 1904: 1,400 patient visits to the Eye & Ear Ward
• 1985: 36,852 visits to the newly opened Kellogg Eye Center
• 2011: 140,104 patient visits and over 5,783 surgical procedures

Funding

• 1884: End-of-year balance in the Eye & Ear Ward Treasury = $2.77
• 2010:
  • Medical School Operating Budget = $18.5M
  • Clinic and Ambulatory Surgery Budget = 20.8M
  • Research Funding = $10.2M

Selected Achievements

• 1994: Kellogg resident, Ron Kurtz, M.D., discovers the femtosecond laser's potential for eye surgery. Further research results in the formation of IntraLase Corp, which produced the first ultrafast laser for clinical applications.
• 2008: Victor Elner, M.D., Ph.D., and Howard Petty, Ph.D., report on a new imaging device that measures metabolic stress to give early warning for eye disease and diabetes.
• 2009: Dr. John Heckenlively reports that patients with a rare blinding retinal disease—autoimmune retinopathy— saw improved vision after taking drugs to suppress their immune systems.
• A study by Dr. Terry Smith and Dr. Raymond Douglas shows that the drug rituximab is effective in treating patients with severe Graves' eye disease who did not respond to standard treatments.
• 2010: A nine-member clinical and research team joins the Department to investigate the effects of diabetes on the retina and to develop better treatments for diabetic retinopathy. One year later, with colleagues across the U-M Health System, they are part of a $3.5M grant to study the multiple complications of diabetes.